Phase Ib/II open-label study of Ad-RTS-hIL-12 + veledimex gene therapy in chemotherapy-responsive locally advanced or metastatic breast cancer patients Meeting Abstract
| Authors: | McArthur, H.; Page, D.; Proverbs-Singh, T.; Solomon, S.; Hudis, C.; Norton, L.; Patil, S.; Henrich, M.; Halpenny, D.; Erinjeri, J.; Yuan, J.; Wong, P.; Jones, C. A.; Escudero, M.; Cai, H.; Zhou, J.; Yang, Y.; Barrett, J. A.; Lebel, F. |
| Abstract Title: | Phase Ib/II open-label study of Ad-RTS-hIL-12 + veledimex gene therapy in chemotherapy-responsive locally advanced or metastatic breast cancer patients |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi87 |
| Language: | English |
| ACCESSION: | WOS:000393912500279 |
| DOI: | 10.1093/annonc/mdw365.59 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 280P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
